ARCHIVES

Velcade Addition Can Improve Graft-Versus-Host Outcomes

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

October 20, 2000

Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation

September 27, 1985

Finasteride Improved Performance Of PSA In Prostate Cancer Prevention Trial

August 25, 2006

DCT Board Committee Recommends Limited Start On In Vitro Screening Program

January 18, 1985

NIH Backs Down Agrees Nurses May Be Hired Into Commissioned Corps

June 13, 1986

Senators Urge Grassroots Support For Health Research Fund Legislation

May 16, 1997